Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
A webinar offered by American Psychiatric Association (APA).
About the Webinar:
This presentation will provide an overview of the current situation in drug use, especially of heroin, other opioids, cocaine, alcohol, cannabis/marijuana, and synthetic cannabis. In addition, the latest information will be presented regarding trends in the use of Amphetamine-Type Substances, such as MDMA, synthetic cathinones, 2c phenethylamines, tryptamines, piperaziines, and methamphetamine. The status of dissociative drugs such as dextromethorphan, ketamine, and phencyclidine will be updated, as well as patterns of use of other club drugs.
Dr. Maxwell will focus on drug use in the US but will also provide information on trends in other countries which can affect our patterns of use. Links to important findings and documents will be included so that the practitioner will have access to more detailed information and suggested tools to use in dealing with families affected by drug abuse.
Date: September 6, 2013
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reﬂect the ofﬁcial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.